Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2025)

Camp4 Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.81 for Q4 2024.

  • For Q4 2024, Equity Ratio rose 135.81% year-over-year to 0.81; the TTM value through Dec 2024 reached 0.81, up 135.81%, while the annual FY2024 figure was 0.81, 135.81% up from the prior year.
  • Equity Ratio for Q4 2024 was 0.81 at Camp4 Therapeutics, up from 7.44 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.81 in Q4 2024 and bottomed at 7.44 in Q3 2024.